Diabetes
Opinion
Guidelines Aren’t For Everybody
Always consider the risks of polypharmacy when considering therapies for your elderly patients.
Program Profile
Reducing or Discontinuing Insulin or Sulfonylurea When Initiating a Glucagon-like Peptide-1 Agonist
This study sought to determine whether patients taking a glucagon-like peptide-1 agonist in combination with insulin and/or a sulfonylurea for...
Commentary
Top 5 Medications That Can Increase Blood Glucose Levels
Several medications can interfere with glycemic control; Dr. Jain discusses ways to manage medications.
News
Colchicine May Benefit Patients With Diabetes and Recent MI
After a recent myocardial infarction, daily low-dose colchicine reduces the risk for cardiovascular events in patients with type 2 diabetes, a...
Latest News
Corticosteroid Injections Don’t Move Blood Sugar for Most
Intra-articular corticosteroid injections pose a minimal risk of accelerating diabetes; the injections may temporarily raise glucose levels.
Latest News
No Compelling Evidence of Pancreatic Cancer Risk With GLP-1s
There is no evidence that GLP-1 RA use increases pancreatic cancer risk compared with basal insulin up to 7 years.
News
Common Diabetes Pills Also Protect Kidneys
SGLT2 inhibitors, used to manage blood sugar by patients with type 2 diabetes, may also protect the heart and kidneys.
Clinical Review
Low-Carbohydrate and Ketogenic Dietary Patterns for Type 2 Diabetes Management
The effective use of low-carbohydrate diets with close and intensive lifestyle counseling and a safe approach to medication management and...
News
Walking Fast May Help Prevent Type 2 Diabetes
A meta-analysis of cohort studies suggests that fairly brisk and brisk/striding walking, independent of the total volume of physical activity or...
News
Meet the newest acronym in primary care: CKM
“This approach not only raises awareness, it also empowers PCPs to diagnose and treat these conditions more holistically.”